Featured Solutions
-
Clinical Pharmacology Studies For NDA Filing
6/18/2024
Need help with inclusion/exclusion criteria for your Phase 2/3 protocol or an unexpected FDA post-marketing amendment? Altasciences offers reliable solutions with a quick start-up.
-
Human Abuse Potential
4/17/2024
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
-
Comprehensive Services CNS Drug Development
4/9/2024
Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.
-
Your Top Partner For Ophthalmic Drug Development
4/9/2024
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Ethnobridging: Clinical Research Capabilities
1/26/2023
Altasciences recruits from a large ethnic population in Southern California and have a dedicated Asian recruitment and outreach department to liaise with our participants.
-
Premier Service Provider For Driving Simulator Clinical Trials
1/26/2023
With over 13,000 drives completed and 10 driving simulators on-site, Altasciences is the ideal full-service provider for your driving simulator clinical trials.
-
Comprehensive Services For Ophthalmology Drug Development
1/26/2023
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
-
Ophthalmic Clinical Research Services
1/26/2023
With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.
-
Selecting The Right Pain Model For Early Phase Analgesic Trials
1/26/2023
Altasciences’ pain experts and neuroscientists are here to guide you in selecting the most appropriate pain model to successfully evaluate the efficacy and safety profile of your study drug.
-
Special And Patient Populations
1/26/2023
Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.